In South Australia, it is illegal to sell peptides, without a prescription, as outlined in the Controlled Substances Act 1984 (SA)
Higher-likelihood alternative causes: In UK clinical guidance, GSM is a common and under-treated driver of dryness, dyspareunia and tissue fragility, and should be actively assessed, particularly in peri-/post-menopausal patients or those with iatrogenic hypo-oestrogenism
) Study #2 As I said, the second study was performed in 2011 by the same group, but with some improvements (IMHO)
Statistically significant increases in thyroid C-cell adenomas were seen at all doses in rats, resulting in systemic exposures that are 15-times the human exposure achieved at 20 mcg/day based on plasma AUC
Drawing 50 units for a 2.5mg dose is very easy to measure accurately